Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Capricor Therap
(NQ:
CAPR
)
20.10
-1.26 (-5.90%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 31, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Capricor Therap
< Previous
1
2
3
4
Next >
Why Capricor Therapeutics (CAPR) Shares Are Trading Lower
October 17, 2024
Capricor Therapeutics shares are trading lower by 2.7% during Thursday's session. The company earlier commenced its public offering of common stock.
Via
Benzinga
CSX Posts Weak Earnings, Joins Lucid Group, Nokia And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
October 17, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 16, 2024
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
October 16, 2024
Via
Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $6,800 Today
October 11, 2024
Via
Benzinga
Forecasting The Future: 9 Analyst Projections For Capricor Therapeutics
October 09, 2024
Via
Benzinga
Here's How Much $100 Invested In Capricor Therapeutics 5 Years Ago Would Be Worth Today
September 30, 2024
Via
Benzinga
Deep Dive Into Capricor Therapeutics Stock: Analyst Perspectives (5 Ratings)
September 20, 2024
Via
Benzinga
Capricor Therapeutics Says Duchenne Muscular Dystrophy Candidate Shows Sustained Cardiac, Skeletal Benefits After 3 Years
October 11, 2024
Capricor Therapeutics announced promising 3-year results from its HOPE-2 extension study for deramiocel in treating Duchenne muscular dystrophy, showing significant cardiac and motor function...
Via
Benzinga
Fastenal Posts Upbeat Earnings, Joins Wells Fargo, JPMorgan And Other Big Stocks Moving Higher On Friday
October 11, 2024
Via
Benzinga
PepsiCo, DocuSign, Robinhood And Other Big Stocks Moving Higher On Tuesday
October 08, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
October 04, 2024
Via
Benzinga
Unveiling 6 Analyst Insights On Capricor Therapeutics
July 02, 2024
Via
Benzinga
What's Going On With Capricor Therapeutics Stock Friday?
June 28, 2024
The biotechnology company said deramiocel increased cardiac function based on several different measures.
Via
Benzinga
Apogee Enterprises Posts Upbeat Earnings, Joins Frontier Group, JetBlue Airways And Other Big Stocks Moving Higher On Friday
October 04, 2024
Via
Benzinga
Nike Reports Weak Sales, Joins Lamb Weston And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
October 02, 2024
Via
Benzinga
IGM Biosciences, CPI Card And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
October 01, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
September 30, 2024
Via
Benzinga
Prime Medicine, MINISO Group, Li Auto, Weibo And Other Big Stocks Moving Higher On Monday
September 30, 2024
Via
Benzinga
Dow Tumbles Over 200 Points; CERo Therapeutics Shares Jump
September 25, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Crude Oil Down Over 1%; Stitch Fix Shares Plummet
September 25, 2024
Via
Benzinga
Exposures
Fossil Fuels
12 Health Care Stocks Moving In Wednesday's Intraday Session
September 25, 2024
Via
Benzinga
Hewlett Packard Enterprise, Nvidia, Progress Software And Other Big Stocks Moving Higher On Wednesday
September 25, 2024
Via
Benzinga
Nvidia, Alibaba, Capricor Therapeutics, TSMC, Tesla: Why These 5 Stocks Are On Investors' Radars Today
September 24, 2024
On Tuesday, major U.S. indices closed higher, with the Dow Jones Industrial Average gaining 0.2% to reach 42,208.22.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Capricor Therapeutics Stock Is Soaring Tuesday
September 24, 2024
Capricor Therapeutics Inc (NASDAQ:CAPR) shares are trading higher Tuesday after the company announced intent to file a biologics license application (BLA) for the full approval of Deramiocel for the...
Via
Benzinga
Week In Review: Nippon Shinyaku Signs $735 Million Deal For DMD Therapy
September 21, 2024
Japan’s Nippon Shinyaku will acquire European rights for a Duchenne muscular dystrophy disease therapy developed by Capricor Therapeutics of San Diego. Nippon Shinyaku will pay $20 million upfront and...
Via
Talk Markets
EXCLUSIVE: Capricor Therapeutics Inks European Expansion, Commercialization Pact For Lead Asset With Japanese Pharma Firm
September 17, 2024
Capricor Therapeutics partners with Nippon Shinyaku for the European commercialization of Duchenne muscular dystrophy treatment, deramiocel, with a potential $1.5 billion in milestone payments from...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
June 11, 2024
Via
Benzinga
What's Going On With Capricor Therapeutics Stock Tuesday?
June 11, 2024
Capricor Therapeutics announced successful completion of a Type-B meeting with the U.S. Food and Drug Administration (FDA).
Via
Benzinga
What's Going On With Capricor Therapeutics Stock Tuesday?
June 04, 2024
Capricor Therapeutics, Inc. (NASDAQ: CAPR) is trading higher Tuesday after the company announced three-year results from the ongoing HOPE-2 open-label extension
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.